multipl
sclerosi
ms
preval
demyelin
diseas
central
nervou
system
cn
affect
approxim
individu
worldwid
gener
mediat
autoimmun
compon
driven
myelin
proteinspecif
proinflammatori
cytokin
secret
tcell
believ
mediat
pathogenesi
disord
onset
ms
typic
occur
age
year
like
autoimmun
disord
women
affect
often
time
men
ms
first
classifi
discret
entiti
dr
jean
martin
charcot
call
disord
la
scleros
en
plaqu
charcot
gave
accur
account
clinic
symptomatolog
patholog
ms
specul
mechan
pathophysiolog
diseas
frequenc
clinicopatholog
correl
divers
array
neurolog
sign
symptom
associ
ms
includ
limb
weak
impair
motor
function
sensori
symptom
visual
symptom
eye
movement
disord
bladder
symptom
sexual
dysfunct
fatigu
ataxia
deaf
spastic
dementia
cognit
impair
although
clinic
progress
ms
variabl
unpredict
sever
distinct
clinic
cours
major
ms
patient
classifi
common
form
ms
relapsingremit
ms
rrm
character
diseas
exacerb
new
symptom
appear
exist
symptom
becom
sever
exacerb
last
variabl
amount
time
follow
period
total
partial
recoveri
diseas
rrm
patient
may
inact
month
year
individu
initi
diagnos
rrm
develop
secondari
chronic
progress
ms
character
accumul
progress
disabl
relaps
progress
ms
rpm
without
secondari
progress
ms
spm
superimpos
relaps
form
progress
ms
distinct
primari
chronic
progress
form
cpm
character
lack
distinct
attack
individu
experi
gradual
onset
diseas
steadi
worsen
symptom
two
addit
form
ms
affect
minor
patient
marburg
variant
ms
affect
less
diagnos
diseas
mark
frequent
occur
relaps
lead
rapidli
accumul
disabl
often
result
total
immobl
death
benign
ms
occur
small
percentag
patient
character
young
age
onset
infrequ
sensori
episod
full
recoveri
etiolog
ms
unknown
part
due
variabl
diseas
suggest
mani
factor
may
involv
spectrum
clinic
syndrom
defin
ms
wide
accept
genet
immunolog
environment
factor
contribut
collect
ms
suscept
strong
influenc
genet
background
ms
diseas
suscept
support
epidemiolog
famili
molecular
studi
worldwid
distribut
ms
skew
area
lower
preval
asia
africa
south
america
area
high
preval
north
america
europ
new
zealand
australia
incid
preval
ms
follow
northsouth
gradient
hemispher
suggest
northsouth
gradient
observ
new
world
reflect
tendenc
individu
northern
europ
migrat
northern
region
unit
state
canada
convers
region
europ
lower
incid
ms
migrat
southern
region
unit
state
south
america
import
genet
background
suscept
ms
support
epidemiolog
studi
demonstr
differ
preval
ms
among
genet
distinct
popul
live
geograph
area
exampl
frequenc
ms
increas
hungarian
bulgarian
caucasian
decent
compar
gypsi
popul
resid
region
similar
situat
exist
australia
new
zealand
european
descent
far
higher
risk
develop
ms
indigen
popul
unit
state
preval
ms
among
peopl
japanes
ancestri
live
pacif
coast
consider
lower
caucasian
live
california
howev
peopl
japanes
descent
live
west
coast
unit
state
slightli
higher
preval
ms
live
japan
suggest
signific
impact
environment
factor
diseas
suscept
genet
influenc
develop
ms
firmli
establish
famili
twin
studi
adopt
studi
demonstr
biolog
rel
patient
ms
greater
likelihood
develop
ms
adopte
convers
famili
member
adopt
individu
ms
increas
risk
develop
disord
lifetim
risk
ms
among
biolog
rel
individu
ms
increas
closer
biolog
relationship
risk
greatest
sibl
affect
individu
especi
sister
decreas
secondand
thirddegre
rel
addit
rate
ms
concord
eight
time
greater
monozygot
dizygot
twin
howev
concord
among
monozygot
twin
suggest
suscept
genet
background
alon
suffici
caus
diseas
inherit
ms
suscept
follow
classic
model
inherit
gener
believ
ms
complex
heterogen
disord
influenc
sever
gene
exert
rel
modest
effect
gene
may
act
independ
epistat
ms
pathogenesi
gene
may
involv
induct
complex
disord
other
may
involv
diseas
progress
confound
genet
studi
ms
year
sever
gene
associ
immun
function
myelin
structur
mitochondria
tent
associ
increas
risk
ms
mani
associ
demonstr
consist
differ
studi
howev
strong
associ
ms
major
histocompat
complex
mhc
class
ii
allel
dqwl
establish
sever
popul
wide
accept
aberr
immun
respons
play
import
role
etiolog
ms
base
associ
ms
gene
involv
immun
respons
immunopatholog
diseas
clinic
respons
ms
patient
immunomodulatori
immunosuppress
treatment
similar
experiment
immunemedi
demyelin
diseas
anim
describ
mhc
class
ii
background
individu
import
diseas
suscept
mani
studi
concentr
mhcpeptid
interact
order
determin
mhc
class
ii
allel
may
confer
diseas
suscept
determin
bind
affin
antigen
peptid
mhc
allel
determin
cell
immunogen
encephalitogenec
vast
major
studi
concern
mhcpeptid
interact
relev
ms
focus
myelin
basic
protein
mbp
antigen
peptid
mbpspecif
cell
demonstr
peripher
blood
ms
patient
normal
individu
frequenc
mbpspecif
cell
tend
higher
ms
patient
control
howev
similar
frequenc
mbpspecif
cell
demonstr
affect
unaffect
famili
member
therebi
suggest
frequenc
mbpspecif
cell
may
link
immunogenet
background
individu
may
prerequisit
rather
consequ
diseas
develop
molecular
mimicri
phenomena
environment
antigen
cross
react
normal
host
cell
compon
may
induc
immun
respons
host
protein
mbp
therefor
individu
higher
frequenc
mbp
reactiv
tcell
may
like
develop
autoreact
tcell
respons
result
environment
nonself
epitop
mimick
mbp
complex
seri
immunolog
mechan
associ
event
peripher
blood
system
well
central
nervou
system
cn
propos
number
immun
abnorm
frequent
observ
ms
patient
one
hallmark
ms
intrathec
secret
oligoclon
antibodi
olicgoclon
band
ocb
found
cn
tissu
csf
greater
ms
patient
use
diagnosi
diseas
ocb
specif
ms
also
found
sever
chronic
inflammatori
cn
condit
either
infecti
cn
lyme
chronic
viral
bacteri
mening
autoimmun
cn
lupu
erythematosu
origin
although
ocb
direct
singl
antigen
antibodi
band
specif
viral
bacteri
self
antigen
desrib
therefor
unclear
whether
intrathec
synthesi
immunoglobuiln
observ
ms
result
presenc
cell
passiv
recruit
cn
pathogenet
relev
cell
cross
blood
brain
barrier
bbb
addit
presenc
ocb
immunolog
marker
diseas
activ
describ
ms
sever
proinflammatori
cytokin
includ
tnftx
infi
osteopontin
upregul
ms
treatment
ms
patient
ifni
result
mark
increas
exacerb
support
model
ms
mediat
autoimmun
diseas
furthermor
increas
tnft
express
proce
relaps
inflammatori
activ
measur
mri
mrna
level
antiinflammatori
cytokin
tgf
declin
overexpress
cytokin
may
involv
diseas
pathogenesi
caus
upregul
mhc
adhes
molecul
express
endotheli
glial
cell
activ
macrophag
recruit
cell
damag
oligrodendrogli
cell
myelin
sheath
directli
solubl
adhes
molecul
eselectin
elev
ms
sera
solubl
eselectin
increas
csf
ms
patient
util
immunosuppress
antiinflammatori
therapi
ms
also
support
autoimmun
compon
diseas
pathogenesi
although
corticosteroid
treatment
alter
longterm
cours
ms
use
effect
treatment
ms
exacerb
demonstr
administr
highdos
steroid
immedi
stop
bbb
leakag
visual
gadoliniumenhanc
mri
number
immunosuppres
chemotherapeut
drug
includ
cyclophosphamid
methotrex
use
treatment
ms
variabl
success
current
two
immunomodulatori
therapi
name
copl
wide
use
treatment
ms
oposs
mani
effect
ifni
includ
recruit
inflammatori
cell
upregul
mhc
adhes
molecul
addit
ifn
shown
lower
exacerb
rate
ms
patient
relaps
remit
cours
inflammatori
activ
demonstr
mri
synthet
polypeptid
consist
random
sequenc
four
amino
acid
block
antigen
present
compet
antigen
peptid
mhc
bind
groov
demonstr
approxim
effect
earli
relaps
remit
ms
experiment
autoimmun
encephalomyel
eae
model
variou
anim
provid
great
insight
immunopathogenesi
ms
indispens
develop
immunomodulatori
therapi
diseas
eae
acut
chronicrelaps
inflammatori
demyelin
diseas
cn
character
inflamm
demyelin
white
matter
lesion
eae
may
induc
number
suscept
inbr
anim
strain
inject
whole
white
matter
individu
myelin
protein
proteolipid
protein
plp
mbp
complet
freund
adjuv
abil
transfer
eae
affect
anim
nayv
anim
cellular
humor
compon
demonstr
eae
immunemedi
autoimmun
diseas
eae
resist
suscept
strain
mice
rat
guinea
pig
bred
ms
associ
particular
mhcclass
ii
background
eae
use
develop
treatment
modal
broad
focus
migrat
encephalitogen
cell
cn
specif
specif
intervent
target
trimolecular
complex
variou
eae
model
contribut
greatli
understand
immunopathogenesi
immunopatholog
ms
continu
great
asset
develop
immunomodulatori
therapi
diseas
infecti
agent
suspect
etiolog
ms
centuri
first
suggest
infecti
agent
may
involv
pathogenesi
ms
came
dr
pierr
mari
pupil
charcot
mari
believ
sever
organ
involv
pathogenesi
ms
either
alon
combin
base
anecdot
associ
acut
infecti
diseas
includ
typhoid
malaria
pneumonia
childhood
exanthemata
onset
diseas
mari
hypothes
ms
trigger
infect
led
chang
blood
vessel
ultim
result
inflammatori
interstiti
reaction
glial
cell
data
implic
infecti
agent
pathogenesi
ms
includ
epidemiolog
evid
childhood
exposur
infecti
agent
increas
diseas
exacerb
viral
infect
geograph
associ
diseas
suscept
evid
ms
cluster
evid
migrat
high
risk
area
influenc
likelihood
develop
ms
abnorm
immun
respons
varieti
microb
analog
anim
model
human
diseas
virus
caus
diseas
long
incub
period
relaps
remit
cours
demyelin
describ
distribut
ms
follow
geograph
distribut
increas
preval
northern
latitud
may
result
genet
environment
influenc
migrat
studi
support
infecti
etiolog
ms
gener
individu
migrat
high
risk
low
risk
area
age
tend
take
risk
ms
howev
individu
migrat
high
risk
low
risk
area
age
acquir
lower
risk
data
suggest
exposur
environment
factor
perhap
infecti
agent
must
occur
age
order
influenc
ms
suscept
report
cluster
epidem
ms
also
support
role
infecti
agent
ms
faro
island
coast
denmark
case
ms
report
howev
occup
faro
island
british
troop
twenti
island
develop
ms
end
war
area
faro
island
ms
epidem
found
correl
locat
british
troop
encamp
initi
outbreak
ms
follow
addit
cluster
diseas
separ
year
propos
origin
cluster
ms
initi
infecti
agent
affect
ms
suscept
individu
age
suscept
individu
harbor
microb
latent
state
adolesc
thu
account
thirteenyear
interv
ms
cluster
faro
island
exampl
ms
epidem
describ
shetlandorkney
island
iceland
key
west
florida
mossyrock
washington
mansfield
massachusett
virus
implic
number
demyelin
diseas
central
nervou
system
anim
human
subject
associ
virus
demyelin
diseas
support
infecti
influenc
develop
ms
demonstr
capabl
infecti
agent
induc
demyelin
persist
year
central
nervou
system
cn
virus
invlov
demyelin
diseas
nonhuman
includ
canin
distemp
viru
cdv
murin
coronaviru
jhm
strain
theiler
mous
encephalomyel
viru
tmev
visna
viru
tmev
mous
enteroviru
belong
famili
picomavirida
typic
found
gut
howev
tmev
occasion
abl
penetr
cn
caus
acut
inflamm
anterior
horm
cell
resembl
poliomyel
patholog
diseas
character
demyelin
preserv
axon
tmev
often
use
model
ms
patholog
anomali
limit
cn
infect
latent
persist
demyelin
mediat
immun
system
occur
long
incub
period
antibodi
myelin
proteolipid
protein
detect
diseas
anim
recurr
demyelin
remyelin
reminisc
relaps
remit
ms
virul
avirul
strain
tmev
identifi
interest
persist
avirlul
strain
caus
chronic
cn
diseas
suscept
mice
tmev
mediat
demyelin
diseas
associ
mhc
class
gene
murin
hepat
viru
mhv
coronaviru
name
suggest
primarili
infect
liver
howev
sever
murin
strain
includ
jhm
strain
neurotrop
caus
enceph
subsequ
cn
demyelin
viru
readili
infect
oligodendrocyt
neuron
kill
anim
howev
viru
establish
persist
infect
astrocyt
anim
surviv
acut
infect
develop
chronic
progress
neurolog
diseas
character
scatter
demyelin
lesion
cn
infiltr
macrophag
lymphocyt
diseas
progress
lymphocyt
infiltr
diminish
demyelin
astrogliosi
increas
lesion
resembl
chronic
plaqu
ms
howev
role
immun
system
patholog
mhc
induc
demyelin
unclear
cn
diseas
occur
absenc
b
cell
cdv
member
morbillivirus
relat
measl
rinderpest
virus
cdv
common
infect
dog
canin
acut
infect
cdv
may
follow
demyelin
encephalomyel
call
subacut
diffus
scleros
enceph
enceph
character
tremor
paralysi
convuls
may
appear
week
month
acut
infect
lesion
observ
show
demyelin
spare
axon
perivascular
cuff
lymphocyt
macrophag
antibodi
cdv
cn
myelin
detect
serum
csf
affect
anim
canin
distemp
demyelin
encephalomyel
strongli
resembl
subacut
scleros
panencph
sspe
patholog
virolog
immunolog
visna
viru
member
lentivirus
includ
human
immunodefici
virus
ii
infect
sheep
visna
viru
result
gait
abnorm
follow
paraplegia
total
paralysi
diseas
cours
variabl
neurolog
sign
typic
correl
elev
csf
protein
pleocytosi
visna
viru
primari
tropism
monocyt
macrophag
transport
cn
infect
monocyt
releas
viral
particl
differenti
macrophag
releas
cn
viru
infect
microglia
lead
recruit
prolifer
cytotox
lymphocyt
ctl
believ
demyelin
lesion
observ
diseas
result
damag
viru
specif
ctl
autoantibodi
exampl
viralinduc
demyelin
diseasesof
man
includ
progress
multifoc
leukoencephalopthi
pml
subacut
scleros
panenceph
sspe
htlvi
associ
myelopathytrop
spastic
paraparesi
ham
tsp
pml
rare
subacut
demyelin
diseas
associ
jc
viru
papoviru
widespread
human
popul
world
wide
approxim
adult
human
seroposit
jc
viru
infect
age
typic
pml
occur
individu
immunocompromis
defect
cellular
immun
report
aid
patient
develop
pml
patient
pml
present
variabl
symptom
depend
locat
cn
lesion
sspe
cn
diseas
children
young
adult
develop
rare
consequ
measl
viru
infect
clinic
cours
sspe
typic
begin
subtl
mental
deterior
follow
lack
coordin
motor
abnorm
clinic
cours
sspe
may
last
either
month
year
ultim
result
coma
death
sspe
patient
high
serum
csf
antibodi
measl
structur
protein
except
membran
protein
cn
lesion
sspe
character
perivascular
cuf
infiltr
lymphocyt
plasma
cell
gray
white
matter
extens
demyelin
increas
hypertroph
astrocyt
also
observ
diseas
cowdri
type
b
inclus
bodi
contain
measl
virusspecif
antigen
found
neuron
glia
howev
intact
measl
viru
particl
absent
brain
materi
sspe
patient
mechan
measl
viru
enter
cn
unknown
develop
sspe
associ
particular
strain
measl
viru
therefor
like
host
factor
requir
rare
disord
occur
human
tlymphotrop
viru
type
htlvi
associ
chronic
progress
neurolog
diseas
known
htlvi
associ
myelopathi
tropic
spastic
paraparesi
hamtsp
clinic
hallmark
hamtsp
gradual
onset
lower
extrem
weak
bowel
bladder
dysfunct
fecal
incontin
babinski
sign
variabl
sensori
loss
onset
hamtsp
gradual
patient
diseas
clinic
indistinguish
chronic
progress
form
ms
cerebrospin
fluid
csf
analysi
hami
tsp
remark
oligoclon
band
direct
htlvi
magnet
reson
imag
mri
demonstr
demyelin
lesion
white
matter
paraventricular
region
hamtsp
brain
swell
atrophi
spinal
cord
although
distinct
plaqu
characterist
ms
observ
hamtsp
loss
myelin
preserv
axon
describ
incub
period
infect
htlvi
develop
hamtsp
typic
long
describ
subsequ
occur
minor
infect
infecti
agent
long
suspect
etiolog
ms
year
sever
virus
bacteria
associ
ms
base
primarili
elev
antibodi
titer
isol
particular
virusbacterium
ms
materi
tabl
despit
extens
effort
associ
ms
particular
pathogen
none
virus
definit
associ
diseas
elev
antibodi
titer
sever
virus
includ
influenza
c
herp
simplex
measl
varicellazost
rubeola
vaccinia
epsteinbarr
mump
human
herp
viru
report
patient
ms
comparison
healthi
control
report
agent
discount
consider
pathogenesi
ms
howev
remain
candid
virus
sever
bacteria
also
identifi
potenti
etiolog
agent
ms
year
ago
spirochet
believ
caus
ms
base
fact
syphili
caus
relapsingremit
inflammatori
diseas
cn
ocb
present
csf
associ
bacteria
ms
suggest
base
observ
increas
antibodi
titer
ms
patient
compar
control
unknown
whether
elev
antibodi
infecti
agent
found
cn
ms
patient
repres
local
product
antibodi
cn
result
resid
lymphocyt
consequ
spillov
circul
serum
antibodi
consequ
damag
bloodbrain
barrier
mani
virus
dispar
famili
tabl
associ
ms
measl
viru
receiv
greatest
consider
meals
viru
establish
persist
tissu
cultur
vivo
case
sspe
chronic
progress
demyelin
diseas
cn
addit
humor
cellular
immun
respons
measl
viru
differ
ms
patient
compar
healthi
control
intrathec
synthesi
measl
specif
antibodi
demonstr
csf
ms
patient
paradox
decreas
measl
specif
ctl
found
ms
patient
compar
healthi
individu
cytoplasm
tubular
structur
resembl
measl
nucleocapsid
found
astrocyt
one
ms
patient
interest
explant
patient
brain
tissu
develop
cytopath
effect
block
pretreat
antimeasl
serum
addit
one
studi
measl
virusspecif
rna
detect
situ
hybrid
brain
materi
patient
howev
subsequ
studi
confirm
result
although
associ
human
retroviru
htlvi
ms
support
possibl
retrovir
etiolog
ms
exclud
absenc
evid
exogen
retroviru
associ
ms
suggest
human
endogen
retrovirus
herv
could
involv
herv
compris
human
dna
implic
trigger
varieti
autoimmun
disord
propos
pathogen
role
herv
base
correl
superantigen
express
endogen
retroviru
term
insulindepend
diabet
mellitu
presenc
autoantibodi
crossreact
herv
protein
patient
system
lupu
eryternatosu
sjtigren
syndrom
put
endogen
retroviru
known
multipl
sclerosi
retroviru
msrv
tent
associ
ms
extens
character
new
famili
human
endogen
retrovirus
design
human
endogen
retrovirusw
hervw
classifi
msrv
member
hervw
famili
msrv
pol
polymeras
gene
encod
retrovir
revers
transcriptas
sequenc
isol
retrovir
particl
releas
leptomening
cell
cultur
csf
ms
patient
addit
pol
sequenc
isol
serum
significantli
higher
percentag
ms
patient
control
interest
protein
hsvi
demonstr
transactiv
msrv
vitro
observ
may
consist
correl
ms
exacerb
viral
infect
sequenc
analysi
msrv
pol
gene
indic
virtual
ident
pol
gene
endogen
famili
express
ms
control
human
tissu
recent
studi
suggest
msrv
pol
sequenc
transcript
activ
express
lymphocyt
ms
patient
control
notabl
initi
studi
msrv
pol
express
frequent
lymphocyt
serum
ms
patient
compar
control
endogen
retrovirus
may
influenc
immun
regul
direct
effect
gene
product
due
integr
site
interact
exogen
virus
autoantigen
possibl
associ
endogen
retrovirus
ms
remain
controversi
warrant
investig
number
model
virusinduc
demyelin
ms
attempt
explain
complex
seri
event
ultim
result
ms
lesion
molecular
mimicri
model
suggest
immun
respons
viral
antigen
crossreact
normal
host
cell
compon
may
contribut
pathogenesi
ms
sever
viral
sequenc
contain
part
human
mbp
sequenc
two
relev
exampl
molecular
mimicri
includ
crossreact
antibodi
protein
herp
simplex
measl
viru
human
intermedi
filament
rabbit
immun
synthet
peptid
contain
sequenc
hepat
b
viru
polymeras
develop
eae
lesion
rabbit
develop
eae
consequ
immun
synthet
peptid
gener
humor
cellmedi
immun
respons
myelin
hepatit
b
polymeras
addit
crossreact
monoclon
antibodi
protein
theiler
murin
viru
oligodendrocyt
demonstr
demyelin
diseas
observ
mice
administ
vpi
monoclon
antibodi
recent
amino
acid
homolog
immunogen
epitop
semliki
forest
viru
sfv
myelin
autoantigen
myelin
basic
protein
mbp
myelin
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
identifi
immun
mice
sfv
protein
induc
signific
lymphocyt
prolifer
sfv
peptid
well
mog
peptid
mbp
plp
peptid
immun
mog
induc
lateronset
chronic
eaelik
diseas
exampl
molecular
mimicri
support
possibl
immunolog
recognit
viral
peptid
suffici
structur
similar
immunodomin
mbp
peptid
may
lead
clonal
expans
mbpreactiv
cell
ms
therefor
virus
known
caus
latent
persist
infect
herp
virus
may
lead
chronic
antigen
stimul
autoreact
cell
clone
second
possibl
mechan
virusinduc
demyelin
nonspecif
bystand
effect
result
reaction
lymphocyt
macrophag
divers
antigen
case
oligodendrocyt
myelin
sheath
could
damag
lymphokin
proteas
releas
activ
macrophag
immun
cell
respons
viral
infect
induct
inflammatori
cytokin
alon
tnfct
shown
induc
demyelin
mechan
viral
stimul
immunocompet
cell
nonspecif
attack
myelin
sheath
could
explain
demyelin
number
infect
divers
virus
mechan
virusinduc
demyelin
also
propos
pathogenesi
hamtsp
suggest
recognit
htlvi
gene
product
cn
result
lysi
glial
cell
cytokin
releas
model
base
observ
htlvi
specif
ctl
restrict
immunodomin
epitop
htlvi
gene
product
demonstr
pbl
csf
hamtsp
patient
frequenc
htlvi
specif
ctl
lower
absent
htlvi
asymptomat
carrier
target
htlvi
specif
ctl
cn
could
either
resid
glial
cell
oligodendrocyt
astrocyt
resid
microglia
infect
htlvi
infiltr
cell
hla
class
ii
normal
express
cn
would
prevent
antigen
present
necessari
ctl
activ
howev
class
class
ii
express
upregul
sever
cytokin
includ
ifn
tnft
induc
htlvi
known
upregul
hamtsp
patient
releas
cytokin
chemokin
product
htlvi
potenti
destruct
cell
cn
similar
mechan
could
explain
viru
induct
demyelin
diseas
ms
demyelin
may
also
develop
consequ
virusinduc
autoimmun
reaction
brain
antigen
indirect
evid
support
theori
come
eae
anim
parainfecti
encephalomyel
human
viru
specif
lymphocyt
prolifer
respons
mbp
unknown
virus
break
immun
toler
forc
host
mount
strong
cellmedi
immun
respons
brain
antigen
viru
replic
may
incorpor
host
antigen
envelop
insert
modifi
coat
cellular
antigen
cell
surfac
biolog
possibl
newli
expos
antigen
may
recogn
treat
host
foreign
presenc
cd
demonstr
envelop
human
cytomegaloviru
hcmv
becom
associ
hcmv
upon
bud
golgideriv
vacuol
earli
egress
specif
antibodi
detect
major
patient
hcmv
viremia
diseas
bone
marrow
transplant
antibodi
found
crossreact
structur
normal
skin
biopsi
altern
lymphotrop
virus
might
interact
immun
regulatori
system
destroy
popul
lymphocyt
stimul
gener
autoreact
lymphocyt
clone
mani
lymphotrop
viru
capabl
transform
infect
cell
render
immort
demonstr
vitro
cell
immort
virus
ebv
capabl
secret
autoantibodi
human
herpesviru
one
latest
infecti
agent
postul
play
role
pathogenesi
ms
beta
herpesviru
seropreval
rate
vari
healthi
adult
worldwid
virion
architectur
similar
herpesvirus
consist
core
contain
linear
doublestrand
dna
icosadeltahdr
capsid
tegument
surround
capsid
envelop
spike
viral
glycoprotein
surfac
although
replic
primarili
tlymphocyt
pleiotrop
viru
either
product
nonproduct
infect
cell
sever
lineag
includ
bcell
microglia
oligodendrocyt
astrocyt
two
variant
describ
base
genom
antigen
biolog
differ
genom
rang
length
kbp
encod
approxim
protein
overal
nucleotid
sequenc
ident
approxim
gene
less
ident
two
variant
one
found
immediateearli
region
eighteen
open
read
frame
uniqu
either
due
close
sequenc
ident
two
virus
absenc
serolog
assay
easili
discrimin
two
variant
often
treat
singl
viru
howev
argu
differ
biolog
cellular
tropism
restrict
endonucleas
profil
two
variant
suffici
classifi
distinct
herpesvirus
rather
vairiant
viru
variant
identifi
caus
agent
exanthem
subitum
account
major
symptomat
infect
infant
howev
variant
yet
clearli
associ
particular
diseas
increas
neurovirul
variant
compar
b
variant
suggest
base
greater
detect
variant
b
variant
csf
children
adult
addit
variant
isol
cn
aid
patient
area
demyelin
attract
candid
possibl
etiolog
agent
ms
sever
reason
primari
infect
usual
occur
first
year
life
involv
ms
consist
epidemiolog
evid
ms
suggest
exposur
etiolog
agent
puberti
particularli
variant
highli
neurotrop
primari
infect
occasion
result
neurolog
complic
includ
mening
menigoenceph
febril
seizur
demonstr
caus
fatal
enceph
aid
patient
individu
immunosuppress
consequ
bone
marrow
transplant
furthermor
neuropathogen
role
suggest
base
develop
varieti
disord
associ
activ
infect
includ
fulmin
demyelin
encephalomyel
subacut
leukoenceph
necrot
enceph
progress
multfoc
leukoencephalopathi
chronic
myelopathi
one
fundament
properti
herpesvirus
tendenc
reactiv
factor
often
lead
herpesviru
reactiv
stress
infect
anoth
agent
also
associ
ms
exacerb
unfortun
mechan
achiev
latenc
reactiv
poorli
understood
herpesvirus
typic
latent
nervou
tissu
structur
identifi
latent
state
therefor
herpesvirus
like
found
electron
microscopi
pleiotroph
infect
cell
lymphoid
nonlymphoid
origin
pleiotrop
could
explain
abnorm
observ
immun
nervou
system
patient
ms
challon
colleagu
suggest
potenti
role
ms
base
unbias
search
nonhuman
dna
represent
differ
analysi
rda
techniqu
base
success
round
subtract
hybrid
pcr
amplif
enrich
dna
sequenc
present
dna
prepar
ms
diseas
materi
control
pbmc
studi
dna
fragment
analyz
one
fragment
found
homolog
mdbp
gene
variant
dna
found
ms
brain
control
brain
howev
monoclon
antibodi
k
protein
dna
bind
protein
detect
brain
tissu
ms
patient
control
ms
brain
nuclear
stain
found
oligodenderocyt
surround
ms
plaqu
frequent
uninvolv
white
matter
studi
establish
causal
link
ms
first
studi
suggest
associ
viru
ms
use
unbias
technolog
associ
ms
also
support
immunolog
molecular
studi
significantli
higher
antibodi
titer
whole
viru
prepar
ms
patient
compar
normal
control
increas
dna
pbmc
ms
patient
pcr
report
preliminari
studi
intrigu
base
methodolog
discrimin
latent
activ
infect
order
distinguish
stage
infect
earli
antibodi
respons
earli
antigen
presenc
serum
dna
nest
pcr
examin
demonstr
serum
dna
correl
activ
infect
found
healthi
individu
origin
report
signific
increas
igm
respons
earli
antigen
demonstr
patient
relaps
remit
form
ms
comparison
healthi
control
individu
neurolog
diseas
increas
igm
respons
earli
antigen
also
observ
group
patient
inflammatori
diseas
addit
studi
confirm
presenc
increas
igm
respons
patient
ms
correl
demonstr
anoth
report
addit
serum
dna
detect
ms
patient
control
consist
healthi
individu
patient
inflammatori
diseas
patient
neurolog
diseas
nih
cohort
expand
includ
total
ms
patient
control
group
continu
demonstr
presenc
dna
serum
approxim
ms
patient
control
subsequ
studi
number
group
reexamin
presenc
serum
dna
ms
patient
overal
result
studi
equivoc
suggest
discrep
report
may
attribut
differ
patient
select
techniqu
reagent
use
extend
observ
cell
free
serum
dna
ms
patient
longitudin
studi
consist
sampl
obtain
ms
patient
follow
prospect
month
period
time
conduct
serum
dna
detect
significantli
fewer
sera
obtain
period
clinic
remiss
data
previou
studi
repres
singl
time
point
studi
analyz
larg
group
ms
patient
time
suggest
statist
greater
likelihood
detect
dna
serum
ms
patient
exacerb
therefor
time
serum
sampl
like
affect
detect
dna
serum
ms
patient
addit
report
support
role
pathogenesi
ms
suggest
presenc
serum
dna
similar
presenc
gadolinium
enhanc
lesion
coincid
clinic
worsen
subset
patient
cellular
immun
respons
compar
ms
patient
control
report
examin
tcell
lymphoprolif
respons
healthi
control
patient
ms
variant
use
whole
viru
lysat
demonstr
differ
either
frequenc
magnitud
prolif
respons
healthi
control
patient
ms
either
variant
howev
significantli
higher
percentag
patient
ms
prolif
respons
variant
compar
healthi
control
present
unknown
whether
increas
frequenc
lymphoproliferatv
respons
lysat
patient
ms
result
higher
seropreval
variant
ms
patient
alter
host
immun
respons
moreov
subsequ
studi
demonstr
amplif
variant
pbmc
serum
urin
ms
patient
control
collect
descript
increas
lymphoprolif
respons
variant
uniqu
amplif
dna
pbmc
serum
urin
ms
patient
support
associ
ms
studi
suggest
highli
neurotrop
variant
rather
b
variant
may
play
role
diseas
therefor
futur
studi
concern
put
associ
ms
must
consid
variant
specif
tropism
immunolog
studi
examin
cellular
immun
respons
tcell
respons
recombin
protein
describ
ms
patient
control
protein
use
studi
clone
b
variant
homolog
lower
precursor
frequenc
specif
tcell
observ
ms
patient
compar
control
impair
tcell
respons
protein
associ
increas
specif
igm
respons
interest
specif
tcell
line
deriv
ms
patient
demonstr
bias
cytokin
profil
mark
inabl
produc
recent
report
tejadasimon
et
al
cross
reactiv
mbp
residu
residu
examin
increas
precursor
frequenc
crossreact
cell
found
ms
patient
compar
healthi
control
importantli
studi
demonstr
relationship
autoreact
immun
respons
mbp
studi
support
associ
ms
suggest
potenti
role
specif
tcell
pathogenesi
ms
via
molecular
mimicri
ms
cn
disord
detail
analysi
brain
materi
paramount
assess
potenti
associ
ms
commens
pathogen
cn
dna
amplifi
brain
ms
patient
control
recent
studi
specif
address
frequenc
control
ms
brain
identifi
infect
cell
phenotyp
patholog
defin
tissu
goodman
et
al
use
situpcr
ispcr
identifi
individu
cell
contain
genom
surgic
biopsi
specimen
ms
patient
present
acut
diseas
receiv
immunomodulatori
therapi
studi
demonstr
high
frequenc
genom
posit
neurogli
inflammatori
cell
present
acutephas
lesion
tissu
oligodendrocyt
predomin
cell
infect
acut
ms
lesion
companion
studi
patholog
defin
materi
brain
autopsi
isol
laser
assist
microdisect
prior
dna
amplif
repres
signific
advanc
pcr
amplif
viru
dna
patholog
undefin
bulk
brain
tissu
dna
amplifi
brain
ms
patient
control
dna
detect
significantli
higher
frequenc
ms
plaqu
compar
brain
tissu
nonm
neurolog
disord
nonm
inflammatori
normal
appear
white
matter
ms
brain
collect
studi
suggest
present
earli
evolut
ms
lesion
may
play
signific
role
demyelin
pathogenesi
ms
relationship
ms
remain
controversi
yet
clearli
defin
addit
serolog
cellular
immun
respons
molecular
clinic
studi
necessari
elucid
role
pathogenesi
ms
chlamydia
pneumonia
oblig
intracellular
bacterium
respiratori
tract
caus
commun
acquir
pneumonia
c
pneumonia
primarili
infect
mucos
surfac
system
dissemin
bacterium
respiratori
tract
may
occur
via
monocyt
macrophag
epidemiolog
evid
suggest
c
pneumonia
like
ubiquit
human
pathogen
sinc
identif
uniqu
chlamydi
speci
c
pneumonia
controversi
associ
sever
nonrespiratori
human
patholog
cardiovascular
system
cn
includ
atherosclerosi
giant
cell
arter
vascul
alzheim
diseas
enceph
hiv
associ
dementia
ms
relationship
c
pneumonia
ms
first
suggest
case
report
demonstr
presenc
bacterium
csf
ms
patient
rapidli
progress
ms
interest
antibiot
treatment
patient
result
mark
clinic
improv
initi
report
extend
larger
studi
examin
presenc
c
pneumonia
rrm
ond
control
studi
approxim
rrm
spm
patient
cultur
posit
c
pneumonia
compar
ond
control
addit
csf
relapsingremit
secondari
progress
ms
patient
pcrposit
c
pneumonia
outer
membran
gene
compar
neurolog
diseas
control
interest
intrathec
antibodi
specif
c
pneumonia
significantli
higher
ms
patient
control
neurolog
diseas
subsequ
studi
group
demonstr
oligoclon
band
could
partial
absorb
csf
major
ms
patient
use
c
pneumonia
antigen
intraperiton
inocul
mice
c
pneumonia
immun
neural
antigen
increas
sever
eae
pcr
studi
attempt
reproduc
pcr
amplif
c
pneumonia
csf
ms
patient
inconsist
sever
studi
report
c
pneumonia
posit
sampl
either
cultur
pcr
other
report
low
posit
rate
c
pneumonia
ms
high
frequenc
detect
c
pneumonia
neurolog
diseas
control
difficulti
assess
potenti
associ
c
pneumonia
ms
similar
involv
case
studi
involv
multipl
ms
cohort
requir
determin
whether
meaning
associ
ubiquit
pathogen
disord
consider
focu
identif
uniqu
viru
exclus
associ
ms
howev
search
msviru
ie
viral
infect
invari
result
ms
present
diseas
free
individu
unsuccess
inabl
identifi
msviru
could
indic
either
singl
viru
caus
ms
put
msviru
yet
identifi
virus
associ
diseas
altern
new
paradigm
emerg
suggest
ms
diseas
process
associ
common
ubiquit
viru
may
act
trigger
genet
immunolog
predispos
individu
sever
exampl
viru
infect
lead
diseas
subset
infect
individu
exampl
virus
associ
multipl
diseas
outcom
differ
subset
individu
includ
ebv
burkitt
lymphoma
nasopharyng
carcinoma
mononucleosi
measl
viru
sspe
jc
viru
pml
hepat
b
c
viru
hepatoma
perhap
relev
exampl
viru
common
certain
popul
result
diseas
minor
infect
htlvi
origin
identifi
tlymphoblastoid
cell
line
hut
patient
diagnos
cutan
tcell
lymphoma
htlvi
first
describ
human
retroviru
htlvi
establish
etiolog
agent
adult
tcell
leukemia
atl
hematolog
malign
first
character
japan
sinc
initi
descript
atl
discoveri
htlvi
viru
associ
inflammatori
chronic
progress
neurolog
diseas
known
htlvi
associ
myelopathytrop
spastic
paraparesi
hamtsp
sever
inflammatori
diseas
million
individu
infect
worldwid
seropreval
rate
endem
area
exceed
major
individu
infect
htlvi
clinic
asymptomat
propens
certain
individu
develop
either
hamtsp
atl
htlvi
associ
inflammatori
diseas
other
remain
clinic
asymptomat
fulli
understood
suggest
host
genet
immun
abnorm
influenc
individu
predisposit
hamtsp
believ
influenc
likelihood
develop
ms
therefor
use
hamtsp
model
chronic
progress
neurolog
diseas
occur
small
percentag
infect
individu
particularli
german
examin
possibl
involv
ubiquit
viru
etiolog
ms
lifetim
risk
htlvi
infect
individu
acquir
hamtsp
lifetim
estim
japan
associ
made
likelihood
develop
either
hamtsp
atl
particular
hla
haplotyp
hamtsp
patient
japanes
decent
increas
frequenc
certain
allel
repres
haplotyp
contrast
japanes
atl
patient
increas
frequenc
b
decreas
frequenc
hla
cwl
compar
control
hla
type
drb
dqb
drb
atl
patient
hla
type
drb
drb
drb
drb
lin
hamtsp
patient
found
mutual
exclus
neuropatholog
hamtsp
indic
immun
mediat
mechan
involv
progress
diseas
furthermor
sever
line
evid
indic
cellular
humor
immun
respons
hamtsp
patient
alter
htlvi
asymptomat
carrier
uninfect
control
immunolog
hallmark
hamtsp
includ
increas
ex
vivo
spontan
lymphoprolifer
absenc
antigen
stimul
presenc
htlvi
specif
ctl
pbl
increas
antibodi
htlvi
sera
csf
natur
killer
cell
tend
diminish
number
activ
hamtsp
although
suggest
diseas
specif
htlvi
strain
dismiss
factor
determin
diseas
suscept
increas
viral
load
implic
pathogenesi
hamtsp
suggest
increas
provir
load
may
predictor
progress
asymptomat
cartier
state
hamtsp
also
suggest
hla
class
allel
may
confer
protect
effect
develop
hamtsp
influenc
provir
load
infect
individu
interest
hla
haplotyp
also
shown
decreas
overal
risk
ms
hla
allel
comparison
studi
cohort
swedish
norwegian
ms
patient
healthi
control
use
pcrsscp
sever
model
immunopathogenesi
hamtsp
propos
model
base
htlvi
induc
immunemedi
respons
cn
either
specif
viral
antigen
cross
reactiv
self
peptid
none
mutual
exclus
propos
model
immunopathogenesi
hamfsp
similar
suggest
ms
therefor
hope
insight
pathogenesi
hamtsp
lead
better
understand
ms
neurolog
disord
neuroaid
viru
mediat
immunopathogenesi
may
occur
subset
infect
individu
possibl
multipl
virus
may
involv
etiolog
ms
particular
virus
trigger
diseas
differ
subset
individu
common
mechan
possibl
mechan
potenti
virus
could
result
ms
recent
suggest
discoveri
cellular
receptor
santoro
colleagu
clearli
demonstr
also
known
membran
cofactor
protein
mcp
cellular
receptor
member
famili
glycoprotein
function
regul
complement
activ
rca
prevent
spontan
activ
complement
autolog
cell
express
human
nucleat
cell
solubl
form
found
plasma
tear
semin
fluid
normal
individu
use
virtual
ubiquiti
human
molecul
surfac
receptor
help
explain
pleiotrop
particular
interest
cd
also
primatespecif
receptor
measl
notabl
measl
viru
dispar
viru
famili
associ
ms
use
receptor
addit
virus
use
variou
member
rca
famili
cellular
receptor
epsteinbarr
viru
also
implic
ms
use
use
sever
echovirus
coxsackievirus
could
virus
share
receptor
common
measl
viru
caus
ms
similar
mechan
theoret
possibl
engag
one
virus
may
result
increas
activ
complement
cascad
autolog
cell
downregul
receptor
abnorm
increas
complement
could
lead
widespread
tissu
damag
cytokin
dysregul
cytolysi
nitric
oxid
product
altern
virus
common
receptor
could
play
role
ms
trigger
either
directli
indirectli
autoimmun
mechan
virus
replic
may
incorpor
host
antigen
includ
receptor
envelop
demonstr
cmv
siv
htlvi
incorpor
receptor
viru
envelop
could
caus
antigen
recogn
treat
host
foreign
phenomenon
could
account
increas
specif
autoantibodi
observ
ms
potenti
influenc
virus
use
member
rca
famili
includ
measl
viru
pathogenesi
ms
may
part
elucid
anim
studi
recent
cd
transgen
mous
infect
measl
viru
describ
measl
viru
infect
transgen
mice
associ
immunosupress
viru
replic
cn
measl
viru
infect
also
associ
cn
diseas
infect
mice
gener
transgen
mous
provid
excel
model
studi
role
measl
viru
infect
cn
diseas
addit
transgen
mous
may
provid
model
studi
neuropathogenesi
infect
cn
fact
viru
extrem
limit
host
rang
may
product
infect
mice
express
receptor
furthermor
recent
studi
demonstr
eae
may
abrog
use
complement
inhibitor
indic
import
role
complement
eae
well
ms
importantli
increas
level
complement
regulatori
protein
demonstr
serum
csf
ms
patient
compar
healthi
control
neurolog
diseas
patient
elev
level
solubl
serum
also
found
inflammatori
diseas
cohort
indic
increas
solubl
serum
may
common
phenomenon
autoimmun
disord
therefor
increas
level
demonstr
serum
csf
ms
patient
may
indic
increas
activ
complet
system
ms
peripher
intrathec
howev
signific
correl
observ
elev
level
serum
solubl
detect
serum
dna
serum
ms
patient
serum
dna
detect
inflammatori
diseas
control
therefor
increas
serum
solubl
common
inflammatori
diseas
gener
immunopathogen
mechan
involv
receptor
like
uniqu
ms
pathogenesi
etiolog
ms
yet
well
defin
epidemiolog
evid
suggest
ms
multifactori
diseas
develop
result
host
genet
immun
respons
environ
sever
line
evid
includ
document
microb
induc
varieti
demyelin
diseas
human
anim
suggest
viru
may
compris
environment
compon
etiolog
disord
mani
virus
propos
etiolog
agent
ms
none
virus
firmli
associ
diseas
pathogenesi
addit
mechan
virushost
interact
may
lead
demyelin
fulli
understood
current
c
pneumonia
receiv
much
attent
potenti
ms
trigger
howev
role
infecti
agent
pathogenesi
ms
unclear
suggest
multipl
agent
may
induc
virusspecif
andor
crossreact
autoimmun
process
result
clinic
diseas
subset
genet
suscept
individu
involv
multipl
infecti
agent
ms
suggest
origin
dr
pierr
mari
year
ago
may
explain
difficulti
identifi
singl
agent
respons
highli
variabl
chronic
diseas
moreov
encourag
extrem
caution
attempt
readili
associ
virus
chronic
progress
neurolog
disord
ms
outlin
review
difficult
determin
caus
effect
particularli
ubiquit
agent
suggest
play
role
diseas
pathogenesi
uniform
assay
design
viral
isol
techniqu
molecular
probe
etc
must
employ
differ
research
group
larg
number
ms
cohort
confirm
viru
associ
